ArticleScientific reports2025
A hybrid variational mode decomposition framework for enhanced cardiac output estimation using impedance cardiography.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Wearable Flexible Sensors for Cardiovascular Disease Monitoring.Advanced materials (Deerfield Beach, Fla.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate cardiac output (CO) estimation from impedance cardiography (ICG) signals is vital for non-invasive monitoring of cardiovascular disorders, including heart failure, arrhythmias, and hemodynamic instability. However, the reliability of ICG-based assessment is often limited by noise artifacts that obscure clinically relevant features. This study introduces a novel three-stage denoising framework integrating Variational Mode Decomposition (VMD), Non-Local Means (NLM), and Discrete Wavelet Transform (DWT) to enhance ICG signal quality for robust CO estimation. The method was validated on the publicly available ReBeatICG dataset, which includes annotated signals from 24 subjects and reflects real-world noise sources such as motion artifacts and baseline drift. Experimental results demonstrate that the proposed VMD-NLM-DWT approach achieves a maximum of 1.2 dB improvement in signal-to-noise ratio (SNR), an average 13% reduction in mean squared error (MSE), and 9% lower percent root mean square difference (PRD) compared to leading two-stage denoising methods. The framework also enhances fiducial point detection (F1-score increase up to 4.4%) and preserves high heart rate variability (HRV) fidelity (correlation coefficient 0.91), with the highest denoising robustness index (DRI) observed across a wide range of noise conditions. These findings confirm that the proposed method outperforms state-of-the-art alternatives in preserving both signal fidelity and clinically significant features under both stationary and non-stationary noise. Furthermore, all performance improvements are statistically validated using paired t-tests and effect size analysis ([Formula: see text], Cohen's [Formula: see text]) and achieves top scores in PSNR and SSIM compared to all baselines. Computational profiling demonstrates feasibility for real-time, continuous cardiac output monitoring in clinical and ambulatory care, supporting its broader application in cardiovascular diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.